Lecture 10 Flashcards

1
Q

Viruses of the respiratory tract

A

Replicate In upper airways, nasal passages, to lower lung bronchioles

> 200 kinds ranging from mild rhinitis (cough, congestion) to severe pneumonia

  • low mortality
  • some treated with anti-viral, most cant (support care only)

seasonal distribution (winter vs summer)

Common mode of transmission (direct or indirect)
Efficient and difficult to control in community

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Influenza Virus

A

Enveloped RNA virus with segmented genome
-8 separate pieces of nucleic acid

Two kinds of spike proteins on envelope

  1. Neuraminidase (N)
    - Degrades protective mucus of respiratory tract , letting virus to surface
    - Release newly-formed viruses
  2. Hemagglutinin (H)
    - Attaches to receptors on respiratory tract

Both proteins essential to virus, immune system targets these to give protective immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Three types of Influenza Virus

A

Influenza Type A

  • Most common, causes most severe symptoms
  • Broad host range (human, birds, pigs)
  • Lots of subtypes and strains (different amino acid structure of H and N spike proteins)
  • 18 H types + 11 N Types

Influenza B

  • Less common and mild symptoms
  • Limited host range (humans and some marine mammals only)
  • Fewer sub types (no H or N labels)

Influenza C
-rare, very mild symptoms (not a global threat with no vaccines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Evolution of influenza type A: Antigenic Drifting Vs Shifting

A

Antigenic Drifting:
During virus replication, random mutations of H or N genes (minor change)
-New virus is only slightly different from parent (variant strain)
-Long period of time
Virus 1 to 1A

Antigenic Shifting:
H and N Genes mix two different flu sub types if they infect same cell
-New cell is a hybrid
-shifting common near close human-animal-avian contact (agriculture)

End result is continuous creation of new stains we have no immunity to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Influenza Type A clinical Features

A

-virus replicates causing host cell damg, inflammation and immune response

1-3 day incubation period before symptoms

  • headache, chills, cough, high fever, extreme weakness, fatigue, runny nose and sore throat (+/- nausea, diarrhea)
  • 4-8 day symptomatic phase + 1-2 week recovery
  • symptoms vary due to age general health
  • contagious 1 day before symptoms + 5 days after

RIsk for secondary bacterial infections
-Dmg to ciliated cells in lungs compromises lung defenses (immunocompromised, elderly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you know if you really have the flu (type A) and not a cold

A

Flu

  • high fever 3-4 days
  • severe headache
  • severe aches and pains
  • severe fatigue
  • early extreme fatigue
  • usual chest discomfort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lab diagnosis

A

Specimens using nasopharyngeal swab

  • best results collected within 5 days of symptoms
  • nasopharyngeal area

Main lab test is nucleic acid amplification (PCR) for viral nucleic acid (Detects A and B)
(restricted to critical pts during flu season)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influenza: Care and Treatment

A

Rest, fever-relief, good nutrition and hydration (other wise healthy people)

Anti-Virals: Oseltamivir (Tamiflu), Zanaivir (Relenza)

  • Block neuraminidase activity of flu type A only
  • work best 24-48 hour of symptoms

Older drugs (amantadine) resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Influenza: Infection Prevention and Control

A

Droplet precautions for atleast 7 days

Flu Vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Influenza Vaccination and Immunity

A

Body produce antibodies to H protein (best also N protein)
-Produced after exposure to virus

Immunity is strain specific (one strain not different ones)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The Flu Vaccine

A

-Contain killed or purified H and N proteins (cant cause flu cause not alive)
-Different formulation for populations
-all contain same virus components
50-60% protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why is protection 50-60% (or sometimes much lower)

A
  1. Flu Virus may change
    - Different strains and sub-types and vaccines types are for whats expected to be circulating
    - decisions made a year in advance (risk for mismatch)
  2. Different pt populations respond differently
    - protection varies according to age, socio-economic status and general health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why do I need to get a flu shot again this year

A

Antibodies you developed last year are gone

New influenza strains for the new year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who should be vaccinated

A
  • Anyone > 6 months who is at risk of complications from influenza
    • Those with chronic cardiac or pulmonary or renal disease, diabetes, immunocompromised patients, etc.
  • Residents of nursing homes
  • Healthy people over age 50
  • Children between 6 months and 2 years
  • Individuals who care for high-risk patients (and others employed in a health-care facility)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who should strongly consider being vaccinated?

A

Healthy people who don’t want to get the flu( or pass it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ebola Virus

A

Enveloped RNA virus with a
“pleomorphic” morphology
No distinct shape

Africa

Broad host range (bats, monkeys, humans)

Hemorrhagic virus

  • bleeding
  • high fever
  • > 70% mortality
17
Q

Mechanism of disease (ebola)

Symptoms appear 8 days after becoming infected and rapidly worsen
-large number of virus found everywhere

A

Transmission via blood or bodily fluids
-Entry into bloodstream through small breaks in skin, ingestion, or contact with mucosal membranes

Replicates in various white blood cells and spreads via lymphatic system

Other cells become secondarily infected

  • Cell death and tissue dmg
  • increased vascular permeability (blood vessels leak), inhibition of blood coagulation, inference with immune response

Therefore: → Uncontrolled blood loss (esp. mucosal tissues and gut), electrolyte imbalance, rash + edema, hypotension = Multi-organ failure leading to death

18
Q

Treatment/ Prevention ebola)

A

No anti-virals (supportive care only)
→ Maintain electrolyte balance
→ Aggressive fluid replacement
→ Maintain blood pressure and oxygenation
→ Nutritional support, pain control, etc

Two vaccines in clinical trials (none used)

19
Q

History

A
  • 31 lab worker get malburg virus in germany after handling African green monkeys
  • First Ebola outbreak in Zaire and Sudan
  • Small outbreak in Africa
  • Ebola introduced into quarantine facility in Virginia via monkeys from Philippines
  • Kikwit outbreak (spread through hospitals and family contact)
  • Gabon Outbreak (infected after eating a chimp, doctor became ill traveling to south Africa)
  • Uganda Outbreak
  • West Africa Outbreak (largest outbreak to date, international spread)
20
Q

What can history say about new viral diseases start and spread

A
  1. Involve zoonotic disease
  2. Outbreak sustained by human to human transmission
  3. International outbreaks are possible
  4. Recognizing and combating new disease is challenging